English
/
Français
Ethics Portal
English
/
Français
Ethics Portal
COVID-19
Overview
mRNA Technology Transfer Hub Programme
Governance
Agreements
Parallel Initiatives
MPP’s projects
Who We Are
About Us
Governance & Team
Business Model
Statutes, By-Laws & Policies
Annual Reports
Careers & RFPs
What We Do
Licensing for Public Health
Our Strategy 2023-2025
Our Strategy for 2023-2025
How Our Mission Will Translate Into Impact
Our Strategic Goals
Video – Our 2023-2025 MPP Strategy
Critical Enablers That Lay The Groundwork
Prioritising Medicines for Licensing
Disease Areas
COVID-19
HIV
Viral Hepatitis
TB
Cancer
Other Disease Areas
Addressing Children’s Needs
Patent Information Tools
MedsPaL
LAPaL
VaxPaL
Long-Acting Therapeutics
Progress
Licences
Access to Medicines Tracker
Contribution to Universal Health Coverage
Endorsements
Impact
News & Publications
News, Events & Press Releases
Messages from the Executive Director
MPP in the Media
MPP Publications
Related Publications
Newsletters & Updates
Partners
Partnering with MPP
Our Stories
Kenya
Ukraine
India
Voices from Friends of MPP
Funders
How to Give or Get a Licence
Contact Us
Overview
MPP’s projects
Progress & Achievements
»
Licences
COVID-19
7 June 2021